Johnson & Johnson has reported three-year clinical remission data for [...]

Poolbeg Pharma has dosed the first patient in a clinical [...]

The Scottish Medicines Consortium (SMC) has accepted TALVEY (talquetamab) for [...]

Viz.ai has entered a collaboration with Johnson & Johnson to [...]

The Scottish Medicines Consortium (SMC) has accepted guselkumab for the [...]

Johnson & Johnson has dropped plans to develop its recently [...]

The National Institute for Health and Care Excellence (NICE) has [...]